Retraction
Physcion 8-O-β-glucopyranoside inhibits clear-cell renal cell carcinoma bydownregulating hexokinase II and inhibiting glycolysis
Paper Information
Record ID:
24923
Journal:
Publication Date:
May 11, 2018
Retraction Date:
December 28, 2020
(4.9 years years ago)
Subjects:
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Elsevier
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1016/j.biopha.2020.111070Additional Notes:
see also: https://scienceintegritydigest.com/2020/02/21/the-tadpole-paper-mill/
Citations (11)
11
Total Citations1
Post-Retraction(9.1%)
10
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
1
Within 1 year
0
After 2+ years
101
Days since retraction (latest)
Discovery and development of tumor glycolysis rate-limiting enzyme inhibitors
Xueyan Sun, Yijiao Peng, Jingduo Zhao et al. (6 authors)
Bioorganic Chemistry
Published: Apr 2021
54 citations
54 citations
101 days after retraction
Retraction Note to: Resibufogenin suppresses tumor growth and inhibits glycolysis in ovarian cancer by modulating PIM1
Qian Li, Chuanwu Jiang, Yan Wang et al. (12 authors)
Naunyn-Schmiedeberg s Archives of Pharmacology
Open Access
Published: Nov 2020
1 citation
1 citation
32 days before retraction
Physcion and Physcion 8-O-β-D-glucopyranoside: Natural Anthraquinones with Potential Anticancer Activities
Muhammad Adnan, Azhar Rasul, Ghulam Hussain et al. (12 authors)
Current Drug Targets
Open Access
Published: Oct 2020
22 citations
22 citations
75 days before retraction
Retraction notice to “Protective autophagy induced by physcion suppresses hepatocellular carcinoma cell metastasis by inactivating the JAK2/STAT3 Axis” [Life Sci. 214 (2018) 124–135]
Xiaoping Pan, Chen Wang, Yan Li et al. (5 authors)
Life Sciences
Published: May 2020
213 days before retraction
Novel Anthraquinone Compounds as Anticancer Agents and their Potential Mechanism
Wei Tian, Chunmiao Wang, Danrong Li et al. (4 authors)
Future Medicinal Chemistry
Published: Mar 2020
82 citations
82 citations
287 days before retraction
<i>Rumex japonicus</i> Houtt.: A phytochemical, pharmacological, and pharmacokinetic review
Yue Sun, George Binh Lenon, Angela Wei Hong Yang
Phytotherapy Research
Published: Dec 2019
15 citations
15 citations
376 days before retraction
RETRACTED: Physcion 8-O-β-glucopyranoside induced ferroptosis via regulating miR-103a-3p/GLS2 axis in gastric cancer
Yingjie Niu, Jinping Zhang, Yalin Tong et al. (5 authors)
Life Sciences
Published: Oct 2019
81 citations
81 citations
445 days before retraction
RETRACTED ARTICLE: Involvement of NORAD/miR-608/STAT3 axis in carcinostasis effects of physcion 8-O-β-glucopyranoside on ovarian cancer cells
Xiaohong Yang, Yimin Yan, Yuhuan Chen et al. (5 authors)
Artificial Cells Nanomedicine and Biotechnology
Open Access
Published: Jul 2019
23 citations
23 citations
535 days before retraction
Physcion 8-O-β-Glucopyranoside Alleviates Oxidized Low-Density Lipoprotein-Induced Human Umbilical Vein Endothelial Cell Injury by Inducing Autophagy Through AMPK/SIRT1 Signaling[RETRACTED]
Xiuli Yang, Guotian Yin, Haiyan Sun et al. (4 authors)
Journal of Cardiovascular Pharmacology
Published: Jul 2019
10 citations
10 citations
546 days before retraction
Physcion and physcion 8-O-β-glucopyranoside: A review of their pharmacology, toxicities and pharmacokinetics
XunLi, Yingjiao Liu, Shifeng Chu et al. (8 authors)
Chemico-Biological Interactions
Published: Jun 2019
62 citations
62 citations
559 days before retraction
RETRACTED: Protective autophagy induced by physcion suppresses hepatocellular carcinoma cell metastasis by inactivating the JAK2/STAT3 Axis
Xiaoping Pan, Chen Wang, Yan Li et al. (5 authors)
Life Sciences
Published: Oct 2018
25 citations
25 citations
790 days before retraction
Quick Stats
Total Citations:
11
Years Since Retraction:
4.9 years
Open Access:
Yes
Last Checked:
Jul 24, 2025